Lineage Cell Therapeutics, Inc. (LCTX): Price and Financial Metrics
LCTX Price/Volume Stats
| Current price | $0.64 | 52-week high | $1.61 |
| Prev. close | $0.90 | 52-week low | $0.61 |
| Day low | $0.61 | Volume | 9,926,000 |
| Day high | $0.74 | Avg. volume | 813,035 |
| 50-day MA | $0.88 | Dividend yield | N/A |
| 200-day MA | $1.02 | Market Cap | 121.12M |
LCTX Stock Price Chart Interactive Chart >
Lineage Cell Therapeutics, Inc. (LCTX) Company Bio
Lineage Cell Therapeutics, Inc. operates as a biotechnology company. The Company offers cell-based therapies and gene marker-based molecular diagnostics for diseases and degenerative conditions. Lineage Cell Therapeutics serves patients in the United States.
LCTX Price Returns
| 1-mo | -27.74% |
| 3-mo | -32.50% |
| 6-mo | -39.05% |
| 1-year | -36.00% |
| 3-year | -70.51% |
| 5-year | -24.88% |
| YTD | -41.28% |
| 2023 | -6.84% |
| 2022 | -52.24% |
| 2021 | 39.20% |
| 2020 | 97.75% |
| 2019 | -2.20% |
Loading social stream, please wait...